Session Abstract – PMWC 2023 Silicon Valley

Showcase Track S1 - January 25 3.30 P.M.-5.00 P.M.,Showcase Track S2 - January 26 1.15 P.M.-4.00 P.M.,Showcase Track S2 - January 27 1.15 P.M.-3.00 P.M.


The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.


Confirmed Presenting Companies:

 Speaker Profile

Ph.D., Ph.D., CEO and Co-Founder, InterOme, InterOme Inc

Biography
Dr. Corina J Shtir holds a Ph.D. from the University of Southern California in Biostatistics with applications in Statistical Genetics and Epidemiology, a postdoctoral degree in neuroscience from the University of California Los Angeles, and a second postdoctoral degree in statistical genetics applied in diabetes at Cambridge, UK. Prior to her current role as President and Co-Founder of InterOme Inc, Dr. Shtir was Global VP and Head of Precision Medicine at Thermo Fisher Scientific, where she led the growth of Thermo Fisher’s Precision Medicine segment into an operation encompassing more than 200 large or national-scale programs with a presence in 100+ countries. She drove new business, research, and product development efforts, expanding the group’s global reach through cross-divisional collaboration and external partnerships.


Clinical & Research Tools Showcase:
InterOme Inc

InterOme provides digital health services for the environment, public, and individual health sectors. Their Integrated Digital Health Platform, which includes a database enhanced with geospatial and real-time data, and their collaboration with lab partners, allow for full process management and precision public health service approaches.

Rapid Operationalization of Environmental & Biothreat Surveillance
InterOme combines digital and laboratory expertise to turn viral and bacterial surveillance into rapid operations

 Speaker Profile

Ph.D., Director of Assay Development, Epic Sciences

Biography
Applying his experience in technology assessment and immunoassay commercialization to the comprehensive liquid biopsy space, David joined Epic Sciences in the fall of 2020. Highlights over the past two years include advancements in prostate cancer assays as well as the development of the DefineMBC liquid biopsy for diagnosis of metastatic breast cancer. Prior to Epic Sciences, David spent 11 years at Thermo Fisher Scientific in the next-gen immunoassay arena for biomarker discovery-to-validation workflows. Highlights include serving as Sr. R&D Manager to lead development of the ProQuantum High Sensitivity Immunoassay, as well as holding roles in the Office of the Chief Scientific Officer, and the corporate COVID-19 diagnostic testing task force. Earlier in David’s career, he developed Luminex xMAP immunoassay automation platforms for PerkinElmer and spent time performing inflammatory disease research at Pfizer. David’s Ph.D. and postdoctoral fellowship research focused on G protein coupled receptor signaling and thrombosis.


Clinical & Research Tools Showcase:
Epic Sciences

 Speaker Profile

PHD, Chief Business Officer, EpiCypher

Biography
Dr. Martis Cowles is a scientist / entrepreneur focused on the democratization and scaling of ultra-sensitive chromatin profiling technologies to unlock the full potential of epigenomics for drug development and clinical research. He first joined EpiCypher to lead their non-dilutive fund-raising efforts, which has been widely successful - securing >$45M in funding to support new technology development. Currently, Dr. Cowles leads EpiCyphers business segment, which oversees fund raising, partnering, licensing, and IP. Martis earned his PhD from the University of California San Diego, studying transcriptional networks that control adult neurogenesis and brain patterning. Prior to joining EpiCypher, Dr. Cowles studied developmental signaling pathways that underlie cortical stem cell function in the developing mouse brain.


Clinical & Research Tools Showcase:
EpiCypher

EpiCypher continuously pushes technology boundaries to deliver innovative products and services to epigenetics and chromatin biology researchers. From our strong scientific expertise and rigor to our focus on customer success, EpiCypher is proud to be an epigenetics company For Scientists, By Scientists.

Leverage quantitative epigenomics for precision medicine
EpiCypher's CUTANA® CUT&RUN/Tag technology is revolutionizing how epigenetic biomarkers can be identified for accelerated drug development.

 Speaker Profile

CEO, Pillar Biosciences

Biography
Randy Pritchard is the Chief Executive Officer of Pillar Biosciences. He has more than 24 years of experience in corporate and commercial strategy, sales and marketing, and driving growth through innovation. He has held positions of increasing responsibilities, including SVP of US Diagnostics marketing, SVP & Lifecycle Leader at the divisions of POC Diagnostic & Core Reagents, and VP of Marketing at Centralized Diagnostics at Roche Diagnostics. He completed his undergraduate studies at Purdue University and his MBA at Indiana Wesleyan University.


Clinical & Research Tools Showcase:
Pillar Biosciences

Pillar Biosciences is the leader in Decision Medicine™, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to quickly and accurately generate data that optimizes selection of precision therapies for cancer patients.

Leveraging NGS To Enable Localized Decision Medicine
Pillar Biosciences is enabling "Decision Medicine" by enabling localized, more accurate, cost effective and efficient NGS testing.

 Speaker Profile

Lead Development & Application Scientist, Launchworks

Biography
Experienced Application and Development Scientist with a demonstrated history of working in the life science industry. 10+ years of R&D/product development in molecular diagnostics industry. Now specializing in design and development for life science commercialization (NGS and Molecular Diagnostics).


Clinical & Research Tools Showcase:
Launchworks

LaunchWorks CDMO is a FDA Registered, ISO 13485 Certified & cGMP Compliant CDMO offering comprehensive services covering product development, custom chemistry formulation, fulfillment, supply chain development and consultation. We are a reliable and fast-acting partner, driving speed to market for Life Sciences Businesses.

Commercialization in the Post COVID-19 Life Science Ecosystem
One of the main sources of risk during commercialization is the development of the products supply chain.

 Speaker Profile

Head Genedata Profiler, Business, Genedata AG

Biography
Tamas has a background in molecular biology and bioinformatics. He has been working in the area of precision medicine since 2002 when he joined a startup in Berlin developing tests for early detection and treatment response prediction using biomarkers for cancer based on DNA methylation. Within the 7 years at Epigenomics he held various roles involving bioinformatics, statistics, and technology development. After Epigenomics, Tamas focused on precision medicine approaches in ovarian cancer for a couple of years before joining Genedata. Tamas has been at Genedata for 13 years now and lead to the formation of the Genedata Profiler business unit, focusing on digitalizing translational research and enabling efficient precision medicine development.


Clinical & Research Tools Showcase:
Genedata AG

Genedata transforms data into intelligence with innovative software solutions incorporating extensive domain knowledge. Leading biopharmaceutical organizations rely on Genedata to digitalize and automate R&D processes. From discovery to clinic, Genedata solutions help maximize the ROI in R&D. Founded in 1997, Genedata is headquartered in Switzerland.

Accelerating Translational & Clinical Research Through Digitaliza
How to accelerate Translational & Clinical Research Through Digitalization

 Speaker Profile

Ph.D., Senior Director, Scientific Affairs, Sampled

Biography
My mission at Sampled is to provide expert technical resources to clients, evaluate and adopt new technologies and to coordinate outreach initiatives designed to promote understanding of the services provided by Sampled to commercial and academic clients around the world. In my time at Sampled, I previously directed our Sample Processing Services laboratories, with oversight of all operations relating to blood fractionation, cell and stem cell culture and nucleic acid extraction. These laboratories have evolved to establish a new paradigm in SMART laboratory operations. I also helped to build the third largest SARS-CoV2 testing lab in the United States. I currently serve as the Director of the Sampled College of American Pathologists (CAP) Biorepository. In my previous career I served on the faculties of Rutgers University and the Baylor College of Medicine with background training as a bench scientist in Genetics and Neurodevelopment.


Clinical & Research Tools Showcase:
Sampled

Sampled SMART Labs mission is to be the lab behind every transformative health innovation. Our vision is a world where we make it faster and easier for health innovators to improve human health by providing comprehensive sample collection and processing solutions.

Sampled supports commercial and academic clinical research
Sampled SMART lab services allow our clients to focus on the objectives of their research.

 Speaker Profile

Vice President, Collaborations, CDD, Inc.

Biography
Scott joined CDD in early 2022 to help refine and grow its new BioHarmony Data Services business. Scott has over 30 years of experience in the pharmaceutical research industry. His career has focused on the development and commercialization of informatics tools and services that improve the drug discovery & development process. Scott has served in multiple senior leadership roles including VP, GM at Tripos, Inc. a Computer Aided Molecular Design company, Co-Founder & CEO of ChemNavigator.com an online chemistry services company which was acquired by Sigma-Aldrich Inc., and Commercial Director of Elsevier Life Sciences Professional Services.


Clinical & Research Tools Showcase:
CDD, Inc.

CDD’s advances science through better data management. It’s flagship product, CDD Vault®, is a hosted informatics solution that allows researchers to organize data and experiments and securely collaborate. CDD also offers the BioHarmony™ Drug Data Store, providing semantic data on preclinical, clinical, and post-approval developments.

ML for Drug Profiles & Bioassay Registration
FAIR commercial Drug profile data and new ML technology for the automated annotation and registration of bioassays.

 Speaker Profile

MBA, CEO, Parker Isaac Instruments

Biography
Ted has been leading new companies in the life science sector in C-Level roles for over 20 years. with a hybrid background in BioPharma Rx, Molecular Dx and medical device sectors. Focused primarily on commercialization of novel products for the oncology market, he has successfully built and led teams that have broken new ground in the field, leading to widespread adoption and value-based pricing.


Clinical & Research Tools Showcase:
Parker Isaac Instruments

Parker Isaac is developing tools and systems to automate the pre-analytic workflow in AP Labs -- from scalpel to slide!

Census-level staging to improve surgical oncology
Introducing a novel device for AP labs that automates and standardizes nodal dissection, saving time & money

 Speaker Profile

CEO, Rarebase

Biography


Clinical & Research Tools Showcase:
Rarebase

 Speaker Profile

M.S., Automation Program Manager, Watchmaker Genomics,

Biography
Eleanor has over 8 years of experience in the automated liquid handling industry along with a Masters of Science in Applied Genomics and a Bachelors of Science in Molecular and Cell Biology, both degrees from UCONN. She was at Tecan for just over a year as the western Applications Team Manager and prior to Tecan, was at Roche (Kapa Biosystems) for over six years as a Sr. Field Automation Scientist.


Clinical & Research Tools Showcase:
Watchmaker Genomics,

Watchmaker applies advanced enzymology to enable breakthroughs in reading, writing, and editing nucleic acids.

Improving DNA and RNA sequencing from FFPE
Watchmaker’s simple, rapid DNA and RNA NGS solutions deliver sensitive performance with FFPE samples

 Speaker Profile

Ph.D., Associate Director, Genomics, Precision for Medicine

Biography
Respected authority in genomic research. Specialized expertise in recombinant protein expression modeling and in vitro diagnostic assay development for cancer mutations. Peerless focus on regulatory study design, analytical accuracy and specificity, execution management, protocol and report writing.


Clinical & Research Tools Showcase:
Precision for Medicine

We provide the Biospecimens and Specialty Labs, a full-service CRO,and Regulatory Support needed for your diagnostic and therapeutic R&D globally. We have built one of the world’s most extensive biobanks and sample collection networks, capable of meeting the stringent needs of any disease research program.

Sent by email
An insider’s look at biospecimen networks that will mitigate assay development failures and regulatory delays.